The findings, published in The BMJ, found that in the Omicron period mRNA vaccine protection against severe Covid-19 was initially high (89 per cent) but waned after primary vaccination Read More
The findings, published in The BMJ, found that in the Omicron period mRNA vaccine protection against severe Covid-19 was initially high (89 per cent) but waned after primary vaccination